Salarius Pharmaceuticals, Inc.

Clinical-stage biopharma developing targeted protein therapies for cancer and viral diseases.

SLRX | NDAQ

Overview

Corporate Details

ISIN(s):: US79400X4043 (+1 more)
LEI:
Country:: United States of America
Address:: 2450 HOLCOMBE BLVD, 77021 HOUSTON
Website:: https://salariuspharma.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Salarius Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for patients with cancer and other diseases with high unmet medical needs. The company's technology aims to correct the dysregulated gene expression that drives disease progression. Its pipeline is built on two primary drug classes: targeted protein inhibitors (TPIs) and targeted protein degraders (TPDs). The lead TPI candidate, seclidemstat (SP-2577), is in Phase 1/2 clinical trials for solid and hematologic cancers like leukemias and lymphomas. The company's TPD candidate, SP-3164, is in IND-enabling studies. Following a merger with Decoy Therapeutics, Salarius is also advancing peptide therapeutics for cancer and respiratory viruses.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Salarius Pharmaceuticals, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Salarius Pharmaceuticals, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Salarius Pharmaceuticals, Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
NANO MRNA Co.,Ltd. Biotech IP generator developing and licensing mRNA therapeutics using proprietary delivery systems.	Japan	4571
NATIONAL RESEARCH CORP AI-powered platform with analytics to measure and improve the healthcare experience for everyone.	United States of America	NRC
NATURAL RESOURCE PARTNERS LP Manages and leases a diverse portfolio of mineral and energy properties for royalty income.	United States of America	NRP
NATURECELL CO.,LTD. Biotech company developing stem cell therapies, food, beverages, and cosmetics.	South Korea	007390
Nautilus Biotechnology, Inc. Developing a proteomics platform for single-molecule analysis to advance life sciences research.	United States of America	NAUT
NEO MARKETING INC. A marketing support firm using a vast consumer panel for data-driven research and PR campaigns.	Japan	4196
Neonode Inc. Licenses optical sensing and computer vision for HMI in automotive and consumer electronics.	United States of America	NEON
Neovacs Develops immunotherapy vaccines for autoimmune diseases & invests in BioTech/MedTech companies.	France	ALNEV
New Frontier Minerals Limited Mineral explorer of rare earths, niobium, uranium, and copper assets in Australia and Zambia.	Australia	NFM
NexGen Energy Ltd. Uranium exploration company developing a high-grade mine to supply global clean energy fuel.	United States of America	NXE